CLN.WA

Celon Pharma S.A.
WarsawPLNEQUITY Healthcare DELAYED
Last price
22.65
▲ 0.05 (0.22%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
22.60
Prev close
22.60
Day high
23.10
Day low
22.20
Volume
33.53K
Market cap
$881.35M
P/E (TTM)
11.10
52W range
18.50 – 23.50

Day trading desk

Current session · delayed
Gap from prior close
+0.44%
Prior close 22.50
VWAP
22.78
-0.56% from price
Relative volume
5.71×
Unusually busy
Session range
4.73%
22.20 – 23.25
Position in range
43%
Mid range
ATR (14D)
0.62
2.74% of price
Prior day high
23.45
PDH
Prior day low
20.45
PDL
Bid / ask spread
Quote not published
Session volume
65.03K
Avg 11.40K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+8.92% +10.1%
1M
+8.13% +4.8%
3M
+8.13% +5.7%
6M
+0.44% -11.4%
YTD
+11.06% -0.9%
1Y
-0.66% -20.8%
3Y
+42.14% -32.9%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on CLN.WA open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
30.00M
Total on file

Fundamentals

TTM · reported
Market cap$881.35M
Enterprise value$1.26B
Revenue (TTM)$254.41M
Gross profit$189.07M
EBITDA$19.16M
Net income$108.32M
EPS (TTM)$2.04
Free cash flow$-24.97M
Total cash$9.09M
Total debt$53.68M
Book value / share$9.82
Shares outstanding38.91M
Float23.82M
Short % of float
Dividend yield
Beta (5Y)0.62

Valuation & profitability ratios

Account required
Trailing P/E11.10
Forward P/E14.16
PEG ratio
Price / sales
Price / book2.31
EV / revenue4.97
EV / EBITDA66.01
Gross margin74.32%
Operating margin-9.75%
Profit margin42.58%
Return on equity22.84%
Return on assets-1.27%
Debt / equity10.15
Current ratio1.20
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item20252024202320222021YoY
Total revenue $177.55M$164.39M$161.91M$169.56M
Operating revenue $177.55M$164.39M$161.91M$169.56M
Cost of revenue $63.17M$66.82M$66.46M$61.72M
Gross profit $114.38M$97.58M$95.45M$107.84M
Selling, general & admin $37.38M
Total operating expense $153.43M$128.57M$133.46M$121.45M
Operating income -$24.87M-$36.81M-$31.00M-$38.00M +32.4%
Net interest income -$2.57M-$1.73M-$681.00K-$2.04M
Pre-tax income -$39.37M-$19.97M-$36.45M-$15.09M
Tax provision -$4.92M$8.16M$2.83M-$3.48M
Net income -$79.36M-$34.45M-$28.12M-$39.28M -130.4%
Net income to common -$79.36M-$34.45M-$28.12M-$39.28M -130.4%
Basic EPS -1.49-0.64-0.55-0.77 -132.8%
Diluted EPS -1.49-0.64-0.55-0.77 -132.8%
EBIT -$24.87M-$36.81M-$17.31M-$34.77M +32.4%
EBITDA -$24.87M-$36.81M$32.71M$9.32M +32.4%
Basic shares 53.26M53.82M51.06M51.02M -1.0%
Diluted shares 53.26M53.82M51.06M51.03M -1.0%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $60.50M +6.9%
Next quarter $0
Current year -0.44 2 $293.80M +20.2%
Next year -0.18 2 $288.73M -1.7%

Analyst targets & ownership

Account required
Mean target$20.44
High target$25.50
Low target$16.00
Implied upside-9.76%
Analyst count5
ConsensusHOLD
Strong buy / Buy0 / 1
Hold2
Sell / Strong sell2 / 0
Held by insiders55.70%
Held by institutions18.36%
Institutions holding17
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
21.02
+7.75% from price
SMA 20
20.87
+8.29% from price
SMA 50
20.42
+10.69% from price
SMA 100
20.68
+9.52% from price
SMA 200
20.98
+7.71% from price
EMA 12
21.15
+7.08% from price
EMA 26
20.85
+8.64% from price
EMA 50
20.70
+9.43% from price
RSI (14)
74.5
Overbought
MACD (12,26,9)
0.30
Hist 0.16
ATR (14)
0.62
2.75% of price
Realised vol 30D
35.9%
Annualised
Bollinger upper
22.05
20, 2σ
Bollinger lower
19.69
20, 2σ
50 / 200 cross
Death
20.42 vs 20.98
Trend bias
Above 200
+7.71%

Options chain

Account required
Expiry
Spot 22.65
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.12
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
35.9%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-18.4%
Peak to trough
Max drawdown 5Y
-71.8%
Peak to trough
ATR 14
0.62
2.75% of price
Beta (reported)
0.62
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.